TIMP-1 gene expression and PAI-1 antigen after unilateral ureteral obstruction in the adult male rat.

BACKGROUND Sustained obstruction of urinary flow invariably leads to inflammation, loss of functional renal structures and progressive deposition of extracellular matrix proteins, culminating in renal fibrosis. Although increased renal tissue inhibitor of matrix metalloproteinase (TIMP-1) expression is one of the early events following experimental hydronephrosis, little is known about its cellular source. Both the recruited macrophage and the resident/recruited (myo)fibroblast have been postulated to be candidate TIMP-1 transcribing cells. Currently, data concerning plasminogen activator inhibitor type 1 (PAI-1) expression in the ligated kidney are unavailable. Our study concentrated on the localization of TIMP-1 expressing cells and PAI-1 immunoreactive cells in the obstructed rat kidney. METHODS Rats were sacrificed 1, 5, 10, 15, 20 and 26 days after unilateral ureteral obstruction (UUO) or sham-surgery (SOR). Leukocyte (OX-1+), macrophage (ED1+) and neutrophil infiltration were analyzed using specific antibodies or nuclear morphology. alpha-Smooth muscle actin (alpha-SMA) immunostaining was measured morphometrically. Mitotic figures and nuclei with an apoptotic morphology were quantified in hematoxylin-eosin (H&E)-stained sections. TIMP-1 mRNA transcribing cells were localized with in situ hybridization (ISH) and identified by subsequent immunostainings for alpha-SMA and macrophages. PAI-1 antigenicity was evaluated immunohistochemically in SOR, contralateral unobstructed kidneys (CUK), and UUO kidneys. RESULTS The number of leukocytes and macrophages in the ligated rat kidney increased progressively in time, starting from day 5 post-surgery when compared with CUKs. Neutrophil accumulation in UUO kidneys became apparent from day 5 and large intraluminal leukocyte clusters (neutrophils and macrophages) were found in the lumen of distended tubules, especially at later stages post-obstruction, when collected urine and tissue samples proved to be sterile upon culture. From day 5 on, the number of apoptotic cells started to predominate the number of mitotic cells in the obstructed kidneys. Interstitial alpha-SMA immunoreactivity in the ligated kidney expanded from day 5 on and was most pronounced in the inner stripe of the outer medulla. As early as 24 hours post-ligation, TIMP-1 mRNA transcribing interstitial cells were detected with ISH, while tubular TIMP-1 expression was sparse. Since at that point in time, no interstitial alpha-SMA expressing cells and only few ED1+ macrophages were present, the bulk of the TIMP-1 mRNA transcription occurred in other interstitial cells. Throughout the study period numerous interstitial TIMP-1 expressing cells were detectable in obstructed kidneys and from day 5 after ligation on, we could identify alpha-SMA+ and to a lesser degree ED1+ macrophages as TIMP-1 transcribing cells. In addition, dilated tubules containing intraluminal leukocyte casts were surrounded by a corona of intact neutrophils in H&E-stained sections and ISH showed that similar tubules were encircled by TIMP-1 mRNA expressing cells. PAI-1 immunoreactivity appeared to diminish in the early phase following urinary outlet obstruction, but emerged in damaged tubules from day 5 to 10 on. In later stages post-ligation, PAI-1+ cells and PAI-1 immunoreactive material were found embedded in the extracellular matrix. CONCLUSIONS Our results confirm that TIMP-1 is active in the early phase of the fibrotic process and we demonstrated that initially TIMP-1 mRNA is transcribed by very few ED1+ macrophages but mainly by other, presently unidentified, interstitial cells. During later stages of post-ligation, both TIMP-1 (transcribed among others by alpha-SMA+ myofibroblasts, ED1+ macrophages, and possibly neutrophils) and PAI-1 are involved in the progression of tubulointerstitial scarring.

[1]  H. S. Kim,et al.  Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice. , 1999, The Journal of clinical investigation.

[2]  G. González-Ávila,et al.  Changes in Matrix Metalloproteinases during the Evolution of Interstitial Renal Fibrosis in a Rat Experimental Model , 1998, Pathobiology.

[3]  S. Dauwe,et al.  Inhibition of the matrix metalloproteinase system in a rat model of chronic cyclosporine nephropathy. , 1998, Kidney international.

[4]  R. Atkins,et al.  Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. , 1998, Kidney international.

[5]  B. Yang,et al.  Cellular apoptosis and proliferation in experimental renal fibrosis. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  P. Higgins,et al.  Cell shape‐dependent pathway of plasminogen activator inhibitor type‐1 gene expression requires cytoskeletal reorganization , 1998, Journal of cellular physiology.

[7]  L. Truong,et al.  Chronic obstructive uropathy in severe combined immunodeficient (SCID) mice: lymphocyte infiltration is not required for progressive tubulointerstitial injury. , 1998, Journal of the American Society of Nephrology : JASN.

[8]  G. D. De Meyer,et al.  RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. , 1998, The American journal of pathology.

[9]  J. Loffing,et al.  Postnatal maturation of renal cortical peritubular fibroblasts in the rat , 1998, Anatomy and Embryology.

[10]  F. Morel,et al.  Inter-regulated balance between gelatinases and tissue inhibitor (TIMP-1) in isolated human glomeruli. , 1998, Renal failure.

[11]  T. Shirasawa,et al.  Mizoribine improves renal tubulointerstitial fibrosis in unilateral ureteral obstruction (UUO)-treated rat by inhibiting the infiltration of macrophages and the expression of alpha-smooth muscle actin. , 1997, The Journal of urology.

[12]  S. Klahr,et al.  Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring. , 1997, Kidney international. Supplement.

[13]  D. Gomez,et al.  Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. , 1997, European journal of cell biology.

[14]  S. Klahr Remarks on behalf of the new editorial team of Kidney International , 1997 .

[15]  M. Gubler,et al.  Development of human fetal kidney in obstructive uropathy: correlations with ultrasonography and urine biochemistry. , 1997, Kidney international.

[16]  S. Dauwe,et al.  Cholesterol feeding accentuates the cyclosporine-induced elevation of renal plasminogen activator inhibitor type 1. , 1997, Kidney international.

[17]  M. Brezis,et al.  Renal microcirculation and tissue damage during acute ureteral obstruction in the rat: effect of saline infusion, indomethacin and radiocontrast. , 1997, Kidney international.

[18]  D. Vaughan,et al.  Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. , 1997, Kidney international.

[19]  A. Eddy Interstitial inflammation and fibrosis in rats with diet-induced hypercholesterolemia. , 1996, Kidney international.

[20]  L. Truong,et al.  Cell apoptosis and proliferation in experimental chronic obstructive uropathy. , 1996, Kidney international.

[21]  S. Klahr,et al.  Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. , 1996, Kidney international.

[22]  M. Martínez-Maldonado,et al.  Role of angiotensin II in the expression and regulation of transforming growth factor-β in obstructive nephropathy , 1995 .

[23]  S. El-Dahr,et al.  Sequential changes in renal expression of renin-angiotensin system genes in acute unilateral ureteral obstruction. , 1995, Kidney international.

[24]  R. Atkins,et al.  Local macrophage proliferation in the progression of glomerular and tubulointerstitial injury in rat anti-GBM glomerulonephritis. , 1995, Kidney international.

[25]  G. Pelz,et al.  Evidence for the tissue inhibitor of metalloproteinases-1 (TIMP-1) in human polymorphonuclear leukocytes. , 1995, European journal of biochemistry.

[26]  J. Diamond Macrophages and progressive renal disease in experimental hydronephrosis. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  A. Michael,et al.  Altered expression of matrix metalloproteinase-2, TIMP, and TIMP-2 in obstructive nephropathy. , 1995, The Journal of laboratory and clinical medicine.

[28]  S. Klahr,et al.  Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. , 1995, Kidney international.

[29]  H. van Goor,et al.  Differential mRNA expression of renal cortical tissue inhibitor of metalloproteinase-1, -2, and -3 in experimental hydronephrosis. , 1995, Journal of the American Society of Nephrology : JASN.

[30]  A. Eddy Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. , 1994, Journal of the American Society of Nephrology : JASN.

[31]  P. Basset,et al.  Cloning of the cDNA encoding rat tissue inhibitor of metalloproteinase 1 (TIMP-1), amino acid comparison with other TIMPs, and gene expression in rat tissues. , 1994, Gene.

[32]  K. Iwata,et al.  Growth‐promoting activity of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) for a wide range of cells A possible new growth factor in serum , 1992, FEBS letters.

[33]  M. Post,et al.  Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis. , 1991, Kidney international.

[34]  D. Belin,et al.  The plasminogen activator/plasmin system. , 1991, The Journal of clinical investigation.

[35]  W. Schürch,et al.  Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[36]  S. Klahr,et al.  Eicosanoid production by isolated glomeruli of rats with unilateral ureteral obstruction. , 1990, Kidney international.

[37]  J. Verhoeven,et al.  Evaluation of the LOGIC system for the rapid identification of members of the family Enterobacteriaceae in the clinical microbiology laboratory , 1990, Journal of Clinical Microbiology.

[38]  S. Klahr,et al.  Effect of leukocyte depletion on the function of the postobstructed kidney in the rat. , 1989, Kidney international.

[39]  P. Meylan,et al.  Relationship between neutrophil-mediated oxidative injury during acute experimental pyelonephritis and chronic renal scarring , 1989, Infection and immunity.

[40]  S. Klahr,et al.  Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney. , 1988, Kidney international.

[41]  Y. DeClerck Purification and characterization of a collagenase inhibitor produced by bovine vascular smooth muscle cells. , 1988, Archives of biochemistry and biophysics.

[42]  G. González-Ávila,et al.  Experimental diffuse interstitial renal fibrosis. A biochemical approach. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[43]  M. Alessi,et al.  Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. , 1988, Blood.

[44]  G. Gobe,et al.  Genesis of renal tubular atrophy in experimental hydronephrosis in the rat. Role of apoptosis. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[45]  P. Meylan,et al.  Influence of inflammation on the efficacy of antibiotic treatment of experimental pyelonephritis , 1986, Antimicrobial Agents and Chemotherapy.

[46]  E. Döpp,et al.  The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in rat recognized by monoclonal antibodies ED1, ED2 and ED3. , 1985, Advances in experimental medicine and biology.

[47]  T. Nagai Morphologic and immunohistologic study of pyelonephritis in rats by various bacteria and fungi. Special reference to inflammatory changes and localization of antigen. , 1984, Nephron.

[48]  S. Klahr,et al.  Pathophysiology of obstructive nephropathy. , 1980, Kidney international.

[49]  F. S. Wright Effects of urinary tract obstruction on glomerular filtration rate and renal blood flow , 1982 .

[50]  T. Miller,et al.  Pyelonephritis: the relationship between infection, renal scarring, and antimicrobial therapy. , 1981, Kidney international.

[51]  R. Nagle,et al.  Unilateral obstructive nephropathy in the rabbit. I. Early morphologic, physiologic, and histochemical changes. , 1973, Laboratory investigation; a journal of technical methods and pathology.

[52]  G. Kalmanson,et al.  Pyelonephritis. I. Observations on the Course of Chronic Non-Obstructed Enterococcal Infection in the Kidney of the Rat ‡ , 1961, The Yale journal of biology and medicine.

[53]  R. Cooke Biology of Disease , 1948, The Yale Journal of Biology and Medicine.